Related Experiment Video
Updated: Oct 18, 2025

09:53
Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
7.4K
Subtype-WESLR: identifying cancer subtype with weighted ensemble sparse latent representation of multi-view data
Wenjing Song1, Weiwen Wang1, Dao-Qing Dai1
1Intelligent Data Center, School of Mathematics, Sun Yat-Sen University, Guangzhou, 510275, China.
Briefings in Bioinformatics
|October 4, 2021
Summary
A new method, subtype-WESLR, integrates existing cancer subtyping results to identify more precise cancer subtypes from multi-omics data. This approach improves personalized cancer treatment strategies for heterogeneous patients.
Area of Science:
- Oncology
- Bioinformatics
- Computational Biology
Background:
- Cancer subtyping is crucial for personalized medicine in heterogeneous cancer patients.
- High-throughput technologies generate multi-omics data for cancer subtyping.
- Existing computational methods yield diverse subtypes even from the same data, presenting a challenge for integration.
Purpose of the Study:
- To develop a novel computational method for accurate and reliable cancer subtyping.
- To effectively integrate information from distinct subtypes identified by various methods.
- To improve the precision of cancer subtyping using heterogeneous omics data.
Main Methods:
- A weighted ensemble sparse latent representation (subtype-WESLR) method was proposed.
- It fuses base clustering from distinct methods as prior knowledge.
- Projects sample feature profiles to a common latent subspace, maintaining local structure and consistency.
Main Results:
- subtype-WESLR demonstrated superior performance compared to competing methods.
- Experiments were conducted on synthetic and eight public multi-view datasets from The Cancer Genome Atlas.
- The method effectively utilizes integrated base clustering for more precise subtype identification.
Conclusions:
- The proposed subtype-WESLR method offers a robust approach for cancer subtyping.
- Integrating diverse subtyping results enhances accuracy and reliability.
- This advancement holds potential for refining personalized cancer treatment strategies.

